
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $532.3M | $638.1M | $743.9M | $728.7M | $715.1M | |
Revenue Growth (YoY) | 19.3% | 19.87% | 16.58% | -2.05% | -1.87% | |
Cost of Revenues | $230.2M | $247.6M | $241.5M | $224.9M | $229.8M | |
Gross Profit | $302.2M | $390.6M | $502.5M | $503.8M | $485.3M | |
Gross Profit Margin | 56.77% | 61.21% | 67.54% | 69.14% | 67.86% | |
R&D Expenses | $92M | $112.4M | $142.5M | $136.2M | $123.2M | |
Selling, General & Admin | $356.3M | $432.3M | $419.9M | $384.2M | $346.9M | |
Other Inc / (Exp) | $118K | $1M | $14.9M | -$11.5M | -$13.7M | |
Operating Expenses | $448.3M | $544.7M | $562.4M | $520.4M | $470.1M | |
Operating Income | -$146.1M | -$154.1M | -$59.9M | -$16.6M | $15.2M | |
Net Interest Expenses | $18.7M | $22.7M | $25.3M | $35.8M | $25.5M | |
EBT. Incl. Unusual Items | -$164.7M | -$175.8M | -$70.3M | -$64M | -$24.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $843K | -$387K | $2.8M | $3.6M | $3.1M | |
Net Income to Company | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Basic EPS (Cont. Ops) | -$1.57 | -$1.55 | -$0.63 | -$0.56 | -$0.21 | |
Diluted EPS (Cont. Ops) | -$1.57 | -$1.55 | -$0.63 | -$0.56 | -$0.21 | |
Weighted Average Basic Share | $105.7M | $113.4M | $116M | $121.1M | $129.8M | |
Weighted Average Diluted Share | $118.3M | $113.4M | $116M | $121.1M | $129.8M | |
EBITDA | -$100.9M | -$104.5M | $9.2M | $23.1M | $44M | |
EBIT | -$146M | -$153.1M | -$43.1M | -$24.1M | $4.8M | |
Revenue (Reported) | $532.3M | $638.1M | $743.9M | $728.7M | $715.1M | |
Operating Income (Reported) | -$146.1M | -$154.1M | -$59.9M | -$16.6M | $15.2M | |
Operating Income (Adjusted) | -$146M | -$153.1M | -$43.1M | -$24.1M | $4.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $144.7M | $181.4M | $184.5M | $179.4M | $177M | |
Revenue Growth (YoY) | 19.13% | 25.33% | 1.74% | -2.77% | -1.32% | |
Cost of Revenues | $61.1M | $68.5M | $55.3M | $57M | $57M | |
Gross Profit | $83.6M | $112.9M | $129.3M | $122.4M | $120.1M | |
Gross Profit Margin | 57.77% | 62.23% | 70.06% | 68.25% | 67.81% | |
R&D Expenses | $25.3M | $30.6M | $36.5M | $33.9M | $30M | |
Selling, General & Admin | $98.4M | $122.8M | $89.1M | $102.7M | $89.7M | |
Other Inc / (Exp) | $13.9M | $1.9M | -$2.3M | $987K | -$770K | |
Operating Expenses | $123.6M | $153.4M | $125.5M | $136.7M | $119.6M | |
Operating Income | -$40M | -$40.5M | $3.8M | -$14.2M | $419K | |
Net Interest Expenses | -- | $7.9M | $9.1M | $8.3M | $4.6M | |
EBT. Incl. Unusual Items | -$44.9M | -$46.5M | -$7.7M | -$21.5M | -$4.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $177K | -$963K | $1.8M | $2.1M | $467K | |
Net Income to Company | -$45M | -$45.6M | -$9.4M | -$23.6M | -$5.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$45M | -$45.6M | -$9.4M | -$23.6M | -$5.4M | |
Basic EPS (Cont. Ops) | -$0.42 | -$0.39 | -$0.08 | -$0.19 | -$0.04 | |
Diluted EPS (Cont. Ops) | -$0.42 | -$0.39 | -$0.08 | -$0.19 | -$0.04 | |
Weighted Average Basic Share | $107.9M | $117.5M | $114.9M | $124.3M | $132.8M | |
Weighted Average Diluted Share | $158.3M | $117.5M | $114.9M | $124.3M | $132.8M | |
EBITDA | -$28.9M | -$24.2M | $15.2M | -$540K | $8.5M | |
EBIT | -$39.9M | -$38.6M | $3.4M | -$11.9M | $219K | |
Revenue (Reported) | $144.7M | $181.4M | $184.5M | $179.4M | $177M | |
Operating Income (Reported) | -$40M | -$40.5M | $3.8M | -$14.2M | $419K | |
Operating Income (Adjusted) | -$39.9M | -$38.6M | $3.4M | -$11.9M | $219K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $532.3M | $638.1M | $743.9M | $728.7M | $715.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $230.2M | $247.6M | $241.5M | $224.9M | $229.8M | |
Gross Profit | $302.2M | $390.6M | $502.5M | $503.8M | $485.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $92M | $112.4M | $142.5M | $136.2M | $123.2M | |
Selling, General & Admin | $356.3M | $432.3M | $422.3M | $384.2M | $346.9M | |
Other Inc / (Exp) | $118K | -$8.3M | $17.3M | -$10.9M | -$12.7M | |
Operating Expenses | $448.3M | $544.7M | $564.8M | $520.4M | $470.1M | |
Operating Income | -$146.1M | -$154.1M | -$62.3M | -$16.6M | $15.2M | |
Net Interest Expenses | -- | $13.3M | $25.3M | $36.5M | $26.6M | |
EBT. Incl. Unusual Items | -$164.7M | -$175.8M | -$70.3M | -$64M | -$24.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $843K | -$387K | $2.8M | $3.6M | $3.1M | |
Net Income to Company | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Basic EPS (Cont. Ops) | -$1.57 | -$1.55 | -$0.63 | -$0.55 | -$0.21 | |
Diluted EPS (Cont. Ops) | -$1.57 | -$1.55 | -$0.63 | -$0.55 | -$0.21 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$100.9M | -$104.1M | $9.2M | $23.1M | $44M | |
EBIT | -$146M | -$152.7M | -$43.1M | -$24.1M | $4.8M | |
Revenue (Reported) | $532.3M | $638.1M | $743.9M | $728.7M | $715.1M | |
Operating Income (Reported) | -$146.1M | -$154.1M | -$62.3M | -$16.6M | $15.2M | |
Operating Income (Adjusted) | -$146M | -$152.7M | -$43.1M | -$24.1M | $4.8M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $638.1M | $743.9M | $728.7M | $715.1M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $247.6M | $241.5M | $224.9M | $229.8M | -- | |
Gross Profit | $390.6M | $502.5M | $503.8M | $485.3M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $112.4M | $142.5M | $136.2M | $123.2M | -- | |
Selling, General & Admin | $432.3M | $422.3M | $384.2M | $346.9M | -- | |
Other Inc / (Exp) | -$8.3M | $17.3M | -$10.9M | -$12.7M | -- | |
Operating Expenses | $544.7M | $564.8M | $520.4M | $470.1M | -- | |
Operating Income | -$154.1M | -$62.3M | -$16.6M | $15.2M | -- | |
Net Interest Expenses | $13.3M | $25.3M | $36.5M | $26.6M | -- | |
EBT. Incl. Unusual Items | -$175.8M | -$70.3M | -$64M | -$24.1M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$387K | $2.8M | $3.6M | $3.1M | -- | |
Net Income to Company | -$175.4M | -$73.1M | -$67.6M | -$27.2M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$175.4M | -$73.1M | -$67.6M | -$27.2M | -- | |
Basic EPS (Cont. Ops) | -$1.55 | -$0.63 | -$0.55 | -$0.21 | -- | |
Diluted EPS (Cont. Ops) | -$1.55 | -$0.63 | -$0.55 | -$0.21 | -- | |
Weighted Average Basic Share | $453.4M | $463.9M | $484.4M | $519M | -- | |
Weighted Average Diluted Share | $453.4M | $463.9M | $484.4M | $523.8M | -- | |
EBITDA | -$104.1M | $9.2M | $23.1M | $44M | -- | |
EBIT | -$152.7M | -$43.1M | -$24.1M | $4.8M | -- | |
Revenue (Reported) | $638.1M | $743.9M | $728.7M | $715.1M | -- | |
Operating Income (Reported) | -$154.1M | -$62.3M | -$16.6M | $15.2M | -- | |
Operating Income (Adjusted) | -$152.7M | -$43.1M | -$24.1M | $4.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $112.5M | $91.2M | $111.4M | $116.3M | $88.1M | |
Short Term Investments | $40.3M | $44.8M | $26.2M | $1M | -- | |
Accounts Receivable, Net | $51.2M | $57.4M | $63.5M | $59.8M | $50.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18M | $24.2M | $18.5M | $18.2M | $21.8M | |
Other Current Assets | $3.3M | $3.3M | $5.1M | $7.6M | $6M | |
Total Current Assets | $276.5M | $275.6M | $273.1M | $247.8M | $203.9M | |
Property Plant And Equipment | $159.7M | $142.4M | $110.3M | $89.1M | $81.4M | |
Long-Term Investments | -- | $2.7M | -- | -- | -- | |
Goodwill | $131.5M | $266.9M | $266.9M | $266.6M | $271.5M | |
Other Intangibles | $17.1M | $128.2M | $107.1M | $86.7M | $67.9M | |
Other Long-Term Assets | $21.1M | $18.8M | $16.8M | $12.9M | $14.2M | |
Total Assets | $678.4M | $910.3M | $841.8M | $756M | $683.2M | |
Accounts Payable | $31.2M | $49.7M | $46.8M | $48.9M | $45.8M | |
Accrued Expenses | $13.6M | $23.2M | $14.6M | $14.5M | $21.1M | |
Current Portion Of Long-Term Debt | -- | -- | $62.9M | -- | $11.6M | |
Current Portion Of Capital Lease Obligations | $13.8M | $15.5M | $11.5M | $11.3M | $11.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $121.4M | $191.5M | $229.9M | $172.6M | $169.2M | |
Long-Term Debt | $308.4M | $447.5M | $428.8M | $409.7M | $338.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $517.9M | $727.9M | $741.9M | $654M | $561M | |
Common Stock | $109K | $118K | $115K | $125K | $134K | |
Other Common Equity Adj | -$4.2M | -$7.9M | -$12.9M | -$11.6M | -$9.1M | |
Common Equity | $160.5M | $182.4M | $99.9M | $102M | $122.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $160.5M | $182.4M | $99.9M | $102M | $122.2M | |
Total Liabilities and Equity | $678.4M | $910.3M | $841.8M | $756M | $683.2M | |
Cash and Short Terms | $152.9M | $136.1M | $137.6M | $117.3M | $88.1M | |
Total Debt | $308.4M | $447.5M | $491.7M | $409.7M | $350M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $112.5M | $91.2M | $111.4M | $116.3M | $88.1M | |
Short Term Investments | $40.3M | $44.8M | $26.2M | $1M | -- | |
Accounts Receivable, Net | $51.2M | $57.4M | $63.5M | $59.8M | $50.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18M | $24.2M | $18.5M | $18.2M | $21.8M | |
Other Current Assets | $3.3M | $3.3M | $5.1M | $7.6M | $6M | |
Total Current Assets | $276.5M | $275.6M | $273.1M | $247.8M | $203.9M | |
Property Plant And Equipment | $159.7M | $142.4M | $110.3M | $89.1M | $81.4M | |
Long-Term Investments | -- | $2.7M | -- | -- | -- | |
Goodwill | $131.5M | $266.9M | $266.9M | $266.6M | $271.5M | |
Other Intangibles | $17.1M | $128.2M | $107.1M | $86.7M | $67.9M | |
Other Long-Term Assets | $21.1M | $18.8M | $16.8M | $12.9M | $14.2M | |
Total Assets | $678.4M | $910.3M | $841.8M | $756M | $683.2M | |
Accounts Payable | $31.2M | $49.7M | $46.8M | $48.9M | $45.8M | |
Accrued Expenses | $13.6M | $23.2M | $14.6M | $14.5M | $21.1M | |
Current Portion Of Long-Term Debt | -- | -- | $62.9M | -- | $11.6M | |
Current Portion Of Capital Lease Obligations | $13.8M | $15.5M | $11.5M | $11.3M | $11.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $121.4M | $191.5M | $229.9M | $172.6M | $169.2M | |
Long-Term Debt | $308.4M | $447.5M | $428.8M | $409.7M | $338.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $517.9M | $727.9M | $741.9M | $654M | $561M | |
Common Stock | $109K | $118K | $115K | $125K | $134K | |
Other Common Equity Adj | -$4.2M | -$7.9M | -$12.9M | -$11.6M | -$9.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $160.5M | $182.4M | $99.9M | $102M | $122.2M | |
Total Liabilities and Equity | $678.4M | $910.3M | $841.8M | $756M | $683.2M | |
Cash and Short Terms | $152.9M | $136.1M | $137.6M | $117.3M | $88.1M | |
Total Debt | $308.4M | $447.5M | $491.7M | $409.7M | $350M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Depreciation & Amoritzation | $45.1M | $48.6M | $52.3M | $47.2M | $39.2M | |
Stock-Based Compensation | $107.6M | $133.3M | $89.5M | $61.9M | $39.9M | |
Change in Accounts Receivable | -$14.9M | $6.9M | -$8.5M | $753K | $7.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.1M | $34.7M | $48.8M | $79M | $63.6M | |
Capital Expenditures | $35.2M | $24.5M | $14.9M | $16.9M | $13.5M | |
Cash Acquisitions | -$10.4M | -$125.4M | -$1.3M | -- | -$3.2M | |
Cash From Investing | -$36.3M | -$160M | $6.1M | $8.5M | -$16.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $134.6M | $234.8M | -- | $200M | |
Long-Term Debt Repaid | -$78K | -$15K | -$217.3M | -$88.3M | -$273M | |
Repurchase of Common Stock | -- | -$45M | -$60.2M | -- | -- | |
Other Financing Activities | -$69K | -$310K | $244K | -- | -$5.8M | |
Cash From Financing | $13.2M | $105.4M | -$37.8M | -$83.4M | -$75.1M | |
Beginning Cash (CF) | $156.4M | $121.2M | $100.7M | $112.7M | $116.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$37.2M | -$19.9M | $17.1M | $4.1M | -$28M | |
Ending Cash (CF) | $121.2M | $100.7M | $112.7M | $116.7M | $89.3M | |
Levered Free Cash Flow | -$49.3M | $10.2M | $33.9M | $62M | $50.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$45M | -$45.6M | -$9.4M | -$23.6M | -$5.4M | |
Depreciation & Amoritzation | $11M | $14.5M | $11.9M | $11.3M | $8.3M | |
Stock-Based Compensation | $32.7M | $27.2M | $16M | $15.1M | $8.2M | |
Change in Accounts Receivable | -$1.6M | $5.3M | -$8.2M | $2.9M | $2.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $799K | $16.5M | $13.6M | $12.7M | $5.9M | |
Capital Expenditures | $7.4M | $6M | $5.4M | $3.7M | $3M | |
Cash Acquisitions | -$6.9M | -$125.4M | -- | -- | -- | |
Cash From Investing | -$9.2M | -$129.9M | $5.6M | -$3.7M | -$6.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -$1K | $791K | -- | -- | |
Long-Term Debt Repaid | -$4K | -$3K | -$5.5M | -$63.3M | -$15M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$3M | |
Cash From Financing | $7.3M | $5.5M | -$1.5M | -$60.8M | -$16M | |
Beginning Cash (CF) | $122.4M | $209M | $94.3M | $169.3M | $104.6M | |
Foreign Exchange Rate Adjustment | -$160K | -$415K | $710K | -$800K | $1M | |
Additions / Reductions | -$1.1M | -$107.9M | $17.7M | -$51.8M | -$16.3M | |
Ending Cash (CF) | $121.2M | $100.7M | $112.7M | $116.7M | $89.3M | |
Levered Free Cash Flow | -$6.6M | $10.5M | $8.2M | $9M | $2.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$165.6M | -$175.4M | -$73.1M | -$67.6M | -$27.2M | |
Depreciation & Amoritzation | $45.1M | $48.6M | $52.3M | $47.2M | $39.2M | |
Stock-Based Compensation | $107.6M | $133.3M | $89.5M | $61.9M | $39.9M | |
Change in Accounts Receivable | -$14.9M | $6.9M | -$8.5M | $753K | $7.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.1M | $34.7M | $48.8M | $79M | $63.6M | |
Capital Expenditures | $35.2M | $24.5M | $14.9M | $16.9M | $13.5M | |
Cash Acquisitions | -$10.4M | -$125.4M | -$1.3M | -- | -- | |
Cash From Investing | -$36.3M | -$160M | $6.1M | $8.5M | -$16.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$78K | -$15K | -$217.3M | -$88.3M | -$273M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$69K | -$310K | -- | -- | -$5.8M | |
Cash From Financing | $13.2M | $105.4M | -$37.8M | -$83.4M | -$75.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$37.2M | -$19.9M | $17.1M | $4.1M | -$28M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$49.3M | $10.2M | $33.9M | $62M | $50.1M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$175.4M | -$73.1M | -$67.6M | -$27.2M | -- | |
Depreciation & Amoritzation | $48.6M | $52.3M | $47.2M | $39.2M | -- | |
Stock-Based Compensation | $133.3M | $89.5M | $61.9M | $39.9M | -- | |
Change in Accounts Receivable | $6.9M | -$8.5M | $753K | $7.8M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $34.7M | $48.8M | $79M | $63.6M | -- | |
Capital Expenditures | $24.5M | $14.9M | $16.9M | $13.5M | -- | |
Cash Acquisitions | -$125.4M | -$1.3M | -- | -- | -- | |
Cash From Investing | -$160M | $6.1M | $8.5M | -$16.4M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $134.6M | $234.8M | -- | $200M | -- | |
Long-Term Debt Repaid | -$15K | -$217.3M | -$88.3M | -$273M | -- | |
Repurchase of Common Stock | -$45M | -$60.2M | -- | -- | -- | |
Other Financing Activities | -$310K | -- | -- | -$5.8M | -- | |
Cash From Financing | $105.4M | -$37.8M | -$83.4M | -$75.1M | -- | |
Beginning Cash (CF) | $559.7M | $390.9M | $550.3M | $470.4M | -- | |
Foreign Exchange Rate Adjustment | -$585K | -$5M | -$126K | $577K | -- | |
Additions / Reductions | -$19.9M | $17.1M | $4.1M | -$28M | -- | |
Ending Cash (CF) | $539.3M | $403M | $554.3M | $443M | -- | |
Levered Free Cash Flow | $10.2M | $33.9M | $62M | $50.1M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.